New Covid-19 antigen test: Fast and reliable results in just 15 minutes

"With the NADAL® Covid-19 antigen test we have developed a test for the broader public. This allows even more people to be tested for Covid-19, meaning any infected individuals can be detected immediately and other people can be protected", says Roland Meissner, managing director of nal von minden GmbH, based in Moers, Germany.
What is so special about the new test? For one, it is the speed. The result is ready in just 15 minutes. The test is carried out on site and does not need to be sent to the laboratory. For another, it is the performance data. Roland Meissner: "Our NADAL® Covid-19 antigen test has a diagnostic specificity of over 99.9 percent and a diagnostic sensitivity of 97.56 percent. This compares favourably to our well-known competitors". The specificity provides information on whether all healthy individuals tested are recognised as being healthy. The sensitivity indicates whether all sick individuals tested are recognised as being sick.
Meissner: "The laboratories are currently lagging behind and need to be relieved. In addition, an international shortage of reagents is looming on the horizon. Our rapid test – in other words, patient-oriented in-vitro diagnostics – can help here".
For the new antigen test, a swab from the mouth or nasopharynx is taken by medical personnel. The specimen is extracted in a buffer solution and then pipetted onto the test cassette. As with a pregnancy test, the result is then easily readable.
Contacts
Gabriele Hellwig
Info@hellwig-pr.de
+494038662480
Images

About nal von minden GmbH
Moers
Subscribe to releases from nal von minden GmbH
Subscribe to all the latest releases from nal von minden GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from nal von minden GmbH
Did my vaccine work? New rapid test for the determination of vaccination success.25.5.2021 14:47:45 CEST | Press release
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease7.1.2021 13:27:50 CET | Press release
Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.
Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 14:48:24 CET | Pressemeddelelse
In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.
New study: Only reliable rapid corona tests make sense3.12.2020 11:58:51 CET | Press release
More and more manufacturers are bringing corona rapid tests onto the market. But only if they provide reliable results does their use in the fight against the pandemic makes sense. The Charité hospital in Berlin, one of the largest university hospitals in Europe, has now reviewed the performance of corona antigen rapid tests. The corona rapid test from nal von minden GmbH proved to be particularly reliable. The NADAL® COVID-19 Ag rapid test has already been used millions of times throughout Europe during the corona pandemic and provides a result within only 15 minutes.
nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:54:07 CET | Press release
Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!